Taro Pharmaceutical Industries Ltd reports results for the quarter ended in December - Earnings Summary

Taro Pharmaceutical Industries

28/01/2022 01:08

* Taro Pharmaceutical Industries Ltd  TARO.N  reported
quarterly
adjusted earnings of 70 cents​​ per share for the quarter ended
in December. The lone analyst forecast for the quarter was
for earnings of 91 cents per share.
    * Revenue fell 0.8% to $138.98 million from a year ago; 
analysts
expected $142.22 million. 
    * Taro Pharmaceutical Industries Ltd's reported EPS for the
quarter was 70 cents​.
    * The mean earnings estimate of analysts had fallen by
about 12.5%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Taro Pharmaceutical Industries Ltd shares had fallen
by 6.4%
this quarter.
    * The company reported quarterly net income of $26.31
million.
    * Wall Street's median 12-month price target for Taro
Pharmaceutical Industries Ltd is $75.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated January 28 at 01:08 a.m.
 ​All figures in US dollars unless otherwise stated